1172MO Durvalumab consolidation in patients with stage III non-resecable NSCLC with driver genomic alterations

Autor:	Ernest Nadal, Gilberto Lopes, Laura Mezquita, R. Lopez Castro, Benjamin Besse, J. Mosquera Martinez, E. Escalera Martín, R. Lobefaro, M.R. Garcia Campelo, N. Dempsey, M. Riudavets Melia, Diego Signorelli, M. Tagliamento, Sara Pilotto, M.A. Mosteiro Lamas, J. Bosch Barrera, David Planchard, G. Zalcman, Margarita Majem, Edouard Auclin
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty Durvalumab Consolidation (soil) business.industry Internal medicine Medicine In patient Hematology Stage (cooking) business
Zdroj:	Annals of Oncology. 32:S940-S941
ISSN:	0923-7534
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::525a6dd80460f7f8f0f0607ffd050a08 https://doi.org/10.1016/j.annonc.2021.08.1776 Zobrazit plný text záznamu